ARS Pharmaceuticals, Inc. has announced the addition of neffy® (epinephrine nasal spray) to the formularies of Cigna Healthcare, Navitus Health Systems, and OptumRx, expanding access to approximately ...

Add Yahoo as a preferred source to see more of our stories on Google. Aug. 26—Those at risk of a severe allergic reaction always have handy an EpiPen just in case. But soon their life might be saved ...

Approximately five months after launch, the inclusion of neffy on these three additional formularies has expanded access to half of all patients and caregivers managing Type 1 allergic reactions, ...

Add Yahoo as a preferred source to see more of our stories on Google. SolStock/Getty This month, the FDA approved a nasal spray version of the drug epinephrine, a potentially ground-breaking ...

While some Australians celebrate access to new medicines, others are forced to fundraise for treatments they desperately need ...

Shares of ARS Pharmaceuticals fell after the company said no commercial insurers had added its neffy nasal spray to their plans in the current insurance cycle. Shares plunged 23% to $8.12 in ...

Good day and welcome to the ARS Pharmaceuticals' neffy (epinephrine nasal spray) FDA Approval Conference call. At this time, all participants are in listen-only mode. After the speakers’ presentation, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...